Ulcerative colitis, infliximab, and hepatic epithelioid hemangioendothelioma: who is to blame? Case Report
- PMID: 21180602
- PMCID: PMC3002576
- DOI: 10.1177/1756283X10363015
Ulcerative colitis, infliximab, and hepatic epithelioid hemangioendothelioma: who is to blame? Case Report
Figures
References
-
- Banerjee B., Rennison A. (1992) Epitheloid haemangioendothelioma of liver: a vascular tumour easily mistaken for metastatic carcinoma on ultrasound imaging. Br J Radiol 65: 611–613. - PubMed
-
- Bardin N., Reumaux D., Geboes K., Colombel J.F., Blot-Chabaud M., Sampol J., et al. (2006) Increased expression of CD146, a new marker of the endothelial junction in active inflammatory bowel disease. Inflamm Bowel Dis 12: 16–21. - PubMed
-
- Biancone L., Calabrese E., Petruzziello C., Pallone F. (2007) Treatment with biologic therapies and the risk of cancer in patients with IBD. Nat Clin Pract Gastroenterol Hepatol 4: 78–91. - PubMed
-
- Cardillo C., Schinzari F., Mores N., Mettimano M., Melina D., Zoli A., et al. (2006) Intravascular tumor necrosis factor alpha blockade reverses endothelial dysfunction in rheumatoid arthritis. Clin Pharmacol Ther 80: 275–281. - PubMed
-
- Dean P.J., Haggitt R.C., O’Hara C.J. (1985) Malignant epithelioid hemangioendothelioma of the liver in young women. Relationship to oral contraceptive use. Am J Surg Pathol 9: 695–704. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
